CLINICAL_TRIALS
trial_result
· 2020-03-27
Clinical Trial Update: Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia. [Phase 3]
Summary
Phase 3 trial updating efficacy and safety data for HP3070 in schizophrenia has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Noven Pharmaceuticals, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2020-03-27